LIVN Q4 2022 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$275M+1.8% YoY

Gross Profit

$184M66.8% margin

Operating Income

$14M5.1% margin

Net Income

$2M0.6% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$10M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.1B

Stockholders' Equity

$1.2B

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$275M	$270M	+1.8%
Gross Profit	$184M	$198M	-7.1%
Operating Income	$14M	$21M	-32.3%
Net Income	$2M	-$9M	+119.4%

Revenue Segments

Cardiopulmonary Segment

$136M50%

Neuromodulation Segment

$127M47%

Advanced Circulatory Support Segment

$10M4%

Geographic Segments

UNITED STATES

$154M56%

Locations Excluding The United States And Europe

$75M27%

Europe

$46M17%